CIK 0001678660 · Non-accelerated filer<br>Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811384762
- Phone
- (302) 467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President, CMO gave up 3,859 shares (to pay taxes)
- 4 Open-market buy CEO bought 5,000 shares at $1.21 ($6,044)
- 4 Open-market buy CEO bought 10,000 shares at $1.20 ($12,000)
- 4 Open-market buy Chief Chemistry Officer bought 63,075 shares at an average $1.36 ($85,538)
- 4 Open-market buy CLO, Interim CFO, Corp Sec. bought 25,000 shares at $0.91 ($22,638)
- 4 Open-market buy CEO bought 106,888 shares at an average $0.93 ($99,326)
- 4 Shares withheld for taxes President, CMO gave up 3,349 shares (to pay taxes)
- 4 Shares withheld for taxes President, CMO gave up 3,347 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President, CMO gave up 3,347 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 10 · 185 filings